logo
HHS slashes funding for mRNA vaccine development

HHS slashes funding for mRNA vaccine development

CNN3 days ago
US Health and Human Services is 'winding down' its mRNA vaccine development and will instead fund other vaccine platforms through the Biomedical Advanced Research and Development Authority, the agency said Tuesday.
HHS Secretary Robert F. Kennedy Jr. said in a statement that BARDA would terminate 22 mRNA vaccine development investments, suggesting the vaccines 'fail to protect effectively against upper respiratory infections like Covid and flu,' despite evidence they protect against severe disease and death from Covid-19 and show promise against influenza. HHS said some final stage contracts will continue, but 'no new mRNA-based projects will be initiated.'
'We reviewed the science, listened to the experts, and acted,' Kennedy said.
'Going forward, BARDA will focus on platforms with stronger safety records and transparent clinical and manufacturing data practices,' HHS said. 'Technologies that were funded during the emergency phase but failed to meet current scientific standards will be phased out in favor of evidence-based, ethically grounded solutions – like whole-virus vaccines and novel platforms.'
Messenger RNA is a single strand of the genetic code that cells can 'read' and use to make a protein. With the Covid vaccine, mRNA instructs cells in the body to make the particular piece of the virus's spike protein. When the immune system sees it, it recognizes it as foreign and is then prepared to attack when there is an actual infection.
The vaccines were particularly useful during the Covid-19 pandemic because they can be developed and manufactured quickly. Multiple peer-reviewed studies have shown that mRNA vaccines developed under Operation Warp Speed during the first Trump administration were highly effective at preventing severe disease and were repeatedly demonstrated to be extremely safe.
The Trump administration and Kennedy, who has a long history of anti-vaccine claims, had previously said they were evaluating mRNA projects. In May, HHS also terminated a $590 million contract with Modern to develop a vaccine to protect against bird flu.
Dr. Peter Hotez, a pediatrician who directs the Center for Vaccine Development at Texas Children's Hospital, said Tuesday's HHS announcement will 'promote their pseudoscience agenda and weaken our nation's biosecurity.'
'The mRNA technology, like all biotechnologies, has strengths and weaknesses, but for a pandemic situation with a new and previously unknown pathogen, or for cancer vaccines and immunotherapeutics it has distinct advantages,' Hotez said. 'HHS under Mr. Kennedy is telling us that we should no longer look to the federal government for innovation in biomedicine. The states are on their own.'
HHS said it is canceling BARDA's award to Moderna/UTMB for an mRNA vaccine for H5N1, known as avian flu. It is also terminating contracts with Emory University and Tiba Biotech. Emory has been working on a dry powder mRNA antiviral platform that could be inhaled and Tiba is working on a platform that uses a nanoparticle carrier technology, according to the BARDA website. HHS also said it is 'de-scoping' mRNA-related work in contracts it has with Luminary Labs, ModeX, and Sequirus.
HHS said it was also rejecting or canceling multiple pre-award solicitations with proposals from Pfizer, Sanofi Pasteur, CSL Sequirus, Gritstone and others. And it was also restructuring collaborations with the US Department of Defense that would impact nucleic acid-based vaccine projects with AAHI, AstraZeneca and HDT Bio.
HHS said the impacted projects were worth about $500 million. 'Other uses of mRNA technology within the department are not impacted by this announcement,' it said.
In a statement, Moderna spokesman Kelly Cunningham said, 'We are not aware of any new contract cancellations by BARDA involving Moderna. As previously announced in May, our pandemic flu contract was canceled, and we do not currently have any active collaboration with BARDA.'
A spokesperson for Gritstone said the company ceased operations 'as a company some time ago.'
AstraZeneca declined to comment.
CNN reached out to Tiba Biotech, Emory, Pfizer, ModeX, Luminary Labs, CSL Seqirus and Sanofi for a response.
Dr. Paul Offit, a vaccine scientist at Children's Hospital of Philadelphia and an outside vaccine adviser to the FDA criticized Kennedy for making 'a policy decision again that contradicts the scientific data.'
'He has said things like the mRNA vaccines are unnecessarily dangerous,' Offit said. 'It's just wrong. I mean it's actually remarkably safe and it's effective.'
'A decision based on cutting back all this funding based on false statements is just hard to watch,' Offit added.
If another pandemic comes 'we'll just be behind the eight ball again,' without additional research into mRNA vaccines. 'All it does is put us at unnecessary risk for no good reason and just a few bad reasons too,' Offit said.
Dr. Jake Scott, an infectious diseases doctor in California who worked many long days treating patients during the Covid-19 pandemic, said he lost several patients early in the pandemic, but the mRNA vaccines brought major changes by safely protecting billions of people from severe disease and death.
'I cannot really convey accurately what a profound difference there was in the hospital pre vaccine and post vaccine and that was thanks to the mRNA technology,' said Scott, a clinical associate professor, medicine - infectious disease with Stanford Medicine.
To hear that HHS was going to eliminate investment in mRNA vaccines, Scott said, is 'really depressing.'
'This just hits differently. It makes me sad. It's kind of heartbreaking,' said Scott.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

4 outgoing International Space Station fliers undock, head for Saturday splashdown
4 outgoing International Space Station fliers undock, head for Saturday splashdown

CBS News

time4 minutes ago

  • CBS News

4 outgoing International Space Station fliers undock, head for Saturday splashdown

Four outgoing International Space Station crew members undocked from the lab complex Friday and set their sights on a Pacific Ocean splashdown Saturday to close out a 148-day mission. Crew 10 commander Anne McClain, pilot Nichole Ayers, Japanese astronaut Takuya Onishi and cosmonaut Kirill Peskov bid their station crewmates farewell, floated into the SpaceX Crew Dragon Endurance, strapped in and undocked from the lab's forward port at 6:15 p.m. Eastern Time. If all goes well, the capsule will plunge back into the discernible atmosphere Saturday morning, splashing down off the southern California coast at 11:33 a.m. EDT. "We really want to leave with gratitude for the absolute privilege of getting to live and work aboard this amazing International Space Station," McClain said in a departure ceremony Tuesday. "All of us are keenly aware that we may never get to do this again. "We've been very pensive over the last days of understanding what we have all got to be a part of. We know that there are some tumultuous times on Earth ... and we want this mission, our mission, to be a reminder of what people can do when we work together, when we explore together." Station commander Onishi then handed a symbolic key to the lab complex — along with command of the ISS — to cosmonaut Sergey Ryzhikov. "I would like to note that our Expedition 73 took place on an anniversary year," Ryzhikov said. "We together celebrated the 50th anniversary of the first joint international spaceflight, Apollo-Soyuz, and the first handshake in space. "We are going to celebrate the 25th anniversary of International Space Station flight in manned mode (in November)," he continued. "History shows that on our beautiful planet, people unfortunately cannot understand each other. But in space we can cooperate effectively. So thank you everybody." Crew 10's departure comes six days after the arrival of their replacements, Crew 11 commander Zena Cardman, pilot Mike Fincke, Japanese astronaut Kimiya Yui and cosmonaut Oleg Platonov. They were launched Aug. 1 aboard the Crew Dragon Endeavour. Since then, the outgoing crew, along with Ryzhikov, cosmonaut Alexey Zubritsky and NASA crewmate Jonny Kim, has been briefing the replacements on the intricacies of station operations, getting them up to speed as quickly as possible. As it turned out, Crew 10 enjoyed a bit of additional time for a "handover" thanks to high winds in the splashdown zone that ruled out a planned Wednesday undocking. The undocking Friday set up a 17.5-hour trip back to Earth. The Crew Dragon's forward-facing Draco thrusters will fire for nearly 10 minutes at 10:39 a.m. EDT Saturday, slowing the capsule enough to drop the far side of the ship's orbit into the atmosphere. Following a southwest-to-northeast trajectory, Endurance is expected to splash down off Southern California at 11:33 a.m., closing out a 147-day, 16-hour, 29-minute mission spanning 2,368 orbits and 62.8 million miles since it launched on March 14. Crew 10 is the first NASA-sponsored crew to land in the Pacific Ocean. All previous NASA Crew Dragon flights ended with splashdowns off the Florida Gulf coast or the Atlantic Ocean. But SpaceX recently decided to change landing locales to make sure any debris from the Crew Dragon's discarded trunk section splashes harmlessly into the Pacific, well away from any populated areas. Two commercial Crew Dragon flights landed in the Pacific earlier this year to pave the way for Crew 10. As with those earlier flights, SpaceX recovery crews will be standing by near the landing site to retrieve the capsule and the astronauts.

Exclusive-Harvard patents targeted by Trump administration
Exclusive-Harvard patents targeted by Trump administration

Yahoo

time11 minutes ago

  • Yahoo

Exclusive-Harvard patents targeted by Trump administration

By Jonathan Stempel (Reuters) - The Trump administration on Friday ordered a comprehensive review of Harvard University's federally funded research programs, and threatened to take title to or grant licenses from the school's lucrative portfolio of patents. In a letter to University President Alan Garber and obtained by Reuters, Commerce Secretary Howard Lutnick accused Harvard of breaching its legal and contractual requirements tied to the research programs and patents. Lutnick also said the Commerce Department has begun a "march-in" process under the federal Bayh-Dole Act that could let the government take ownership of the patents or grant licenses. Signed in 1980, that law ensures that Americans benefit from inventions funded through taxpayer dollars, a senior administration official said. "The Department places immense value on the groundbreaking scientific and technological advancements that emerge from the Government's partnerships with institutions like Harvard," Lutnick wrote. He said that carried a "critical responsibility" for Harvard to ensure that its intellectual property derived from federal funding is used to maximize benefits to the American people. Harvard did not immediately respond to requests for comment. President Donald Trump has made bolstering the country's manufacturing and economic competitiveness a priority of his second White House term, including by raising tariffs on imports from dozens of countries. ADDED PRESSURE Friday's letter ratchets up White House pressure on Harvard, which it has accused of civil rights violations for failing to address antisemitism on campus. Harvard sued in April after the administration began stripping or freezing billions of dollars of federal research money. Lutnick demanded that Harvard provide by September 5 a list of all patents stemming from federally funded research grants, including how the patents are used and whether any licensing requires "substantial U.S. manufacturing." As of July 1, 2024, Harvard held more than 5,800 patents, and had more than 900 technology licenses with over 650 industry partners, according to a university website. Other schools that have faced federal funding losses have included Columbia University, which last month agreed to pay more than $220 million to settle the government's antisemitism claims. The New York Times has said Harvard was open to spending up to $500 million to settle similar claims. Signed by President Jimmy Carter about six weeks before he left the White House, the bipartisan Bayh-Dole Act was sponsored by Senators Birch Bayh of Indiana and Bob Dole of Kansas. Carter said at the time it was important that industrial innovation promote U.S. economic health, and the legislation "goes far toward strengthening the effectiveness of the patent incentive in stimulating innovation in the United States." Many civil rights experts, faculty and White House critics believe the Trump administration's targeting of schools is a pretext to assert federal control and threaten academic freedom and free speech.

A fiery meteor that punched through a Georgia home's roof is older than Earth, a scientist says
A fiery meteor that punched through a Georgia home's roof is older than Earth, a scientist says

Washington Post

time17 minutes ago

  • Washington Post

A fiery meteor that punched through a Georgia home's roof is older than Earth, a scientist says

ATHENS, Ga. — A meteorite that punched a hole i n a Georgia homeowner's roof after blazing across the sky in a fiery streak is older than the Earth itself, according to scientist who examined fragments of the space rock. People in several Southern states reported seeing the mysterious fireball in broad daylight on June 26 as it hurtled toward the ground faster than the speed of sound.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store